A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients

By Jansen CAM  

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 2995-2999

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon ® ) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP ® ) in a fixed-dose regimen in women undergoing ovarian stimulation

By Hoomans Eric H.M.  

Human Reproduction, Vol. 14, Iss. 10, 1999-10 ,pp. : 2442-2447

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Recombinant follicle stimulating hormone in in-vitro fertilization treatment—clinical experience with follitropin alpha and follitropin beta

By Harlin Jonas   Csemiczky G.   Wramsby H.  

Human Reproduction, Vol. 15, Iss. 2, 2000-02 ,pp. : 239-244

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Comparison of two recombinant follicle-stimulating hormone preparations in in-vitro fertilization: a randomized clinical study

By Tulppala Maija   Aho Milla   Tuuri Timo   Vilska Sirpa   Foudila Tuija   Hakala-Ala-Pietilä Tiina   Moilanen Jarna   Bützow Tarja   Kaukoranta Seija   Söderström-Anttila Viveca   Siegberg Rita   Suikkari Anne-Maria  

Human Reproduction, Vol. 14, Iss. 11, 1999-11 ,pp. : 2709-2715

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization

By Sills E.Scott  

Human Reproduction, Vol. 14, Iss. 9, 1999-09 ,pp. : 2230-2235

Oxford University Press

Access to resources Recommend Favorite